Determination of Pre/Post Treatment Changes in Prostate Specific Antigen Levels in Patients with Acute Prostatitis
Journal Title: Translational Research in Urology - Year 2022, Vol 4, Issue 1
Abstract
Introduction: Given that studies on the association between pre/post-treatment PSA levels in acute prostatitis are limited and investigations in men from different communities are few, the present study aimed to determine the pre/post-treatment changes in the prostate-specific antigen (PSA) levels in patients with acute prostatitis. Method: The current cross-sectional study was conducted in 2020 on a population of men with acute prostatitis. The patients were then referred to a laboratory to measure PSA levels for a definitive diagnosis of acute prostatitis. Prostate volume was determined using ultrasound. Afterward, drug treatment was started for the patient, followed by monitoring. The PSA levels were re-measured, and prostate volume was recorded after treatment. Patient information included patient profile, age, date of the first visit, PSA level at the baseline (before treatment), diagnosis of acute prostatitis, time to start treatment, time to end treatment, PSA level after treatment, and prostate volume. Results: The mean and standard deviation of the age of these patients was 59.90±6.31 years old. The results showed a significant relationship between age and primary PSA at the beginning of diagnosis and PSA reduction. (P-value<0.05). There is a significant relationship between age and duration of treatment (P-value=0.001). The duration of treatment was significantly related to the reduction of PSA, the amount of primary PSA at the beginning of diagnosis, and the amount of secondary PSA after treatment (P-value<0.05). Conclusion: The study's findings can be concluded that the duration of treatment can effectively reduce the level of PSA in patients with acute prostatitis. Extensive studies with a control group for future studies are recommended. Graphical Abstract
Authors and Affiliations
Hamid Mazdak; Zahra Zandi Mashhadi; Kia Nouri Mahdavi; Reza Kazemi
Keywords
Related Articles
- EP ID EP704307
- DOI 10.22034/TRU.2022.323475.1097
- Views 102
- Downloads 0
The Characteristics and Outcomes of Patients Treated with Percutaneous Nephrolithotomy According to the Preoperative Renal Function Levels
Introduction The principles of nephrolithiasis therapy in patients with chronic kidney disease are the same as in patients with normal kidneys. Percutaneous nephrolithotomy (PNL) is the standard treatment for patients w...
Acupuncture for Treatment of Overactive Bladder
Overactive bladder (OAB) is defined as bladder storage dysfunction, which results in a frequent and sudden urge to urinate. OAB is a prevalent disorder, and its symptoms have a detrimental effect on health-related qualit...
Combined Direct Visual and Imaging Guided Percutaneous Nephrolithotomy: A Novel Technique
Introduction Percutaneous nephrolithotomy (PCNL) is a common urological procedure. Obtaining secure percutaneous access to the collecting system which is usually done under fluoroscopic guidance and tract dilatation is...
Primary Huge Retroperitoneal Mucinous Cystadenoma in an Iranian Woman : A Case Report
Introduction Primary retroperitoneal mucinous cystadenoma is a rare tumor among women. Herein, we present a 47-year-old Iranian woman complaining of abdominal discomfort for six months. Case presentation The patient a...
Antibacterial and Antibiofilm Activities of Nisin from Lactococcus lactis and Alteration of the Bacteria-Induced Pro-Inflammatory Responses on kidney and bladder tumor Cell Lines
Introduction: The emergence of superbugs puts the world into an antibiotic-resistance era, and antimicrobial peptides could solve this severe problem. The aim of this study was the in vitro evaluation of the bactericidal...